Study protocol for a randomised, double-blind, placebo-controlled clinical trial of duloxetine for the treatment and prevention of musculoskeletal pain: altering the transition from acute to chronic pain (ATTAC pain)

INTRODUCTION: Chronic musculoskeletal pain affects a substantial portion of adults visiting the emergency department (ED). Current treatment is limited in scope and does not effectively reduce musculoskeletal pain in patients. The study will evaluate the use of duloxetine, a serotonin-norepinephrine...

Descripción completa

Detalles Bibliográficos
Autores principales: Strauss, Daniel H, Santhanam, Divya R, McLean, Samuel A, Beaudoin, Francesca L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Emergency Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430024/
https://www.ncbi.nlm.nih.gov/pubmed/30842115
http://dx.doi.org/10.1136/bmjopen-2018-025002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430024/
https://www.ncbi.nlm.nih.gov/pubmed/30842115
http://dx.doi.org/10.1136/bmjopen-2018-025002

Ejemplares similares